ClinicalTrials.gg
RecruitingNCT05004051Updated Sep 19, 2025

ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA

An observational study in Abdominal Aortic Aneurysms, sponsored by ViTAA Medical Solutions. Recruiting at 8 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-19.

Sponsored by ViTAA Medical Solutions · Observational

How we know

From the registry’s dates

  • Started Dec 2021; still recruiting 4 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 122 studies in Aortic Aneurysm, Abdominal with a site in United States — 28 open to participants now, 34 under way, 1 of them phase 3. Aortic Aneurysm, Abdominal · United States.

Planned enrollment
17th of 32
200 · median 210
Started
2021
with 6 others
Observational
32 of 122
9 open now
Primary completion
2026-12
later than 8 of 33 live
Registered
100th of 122
by date

Among the 122 studies in Aortic Aneurysm, Abdominal with a site in United States, this one is the 17th largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2021, is one of 32 observational ones, reaches primary completion later than 8 of the 33 other live ones, and was the 100th registered.

Aortic Aneurysm, Abdominal

467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.

Browse Aortic Aneurysm, Abdominal studies →

Open to participants now

28 of the 122 studies in Aortic Aneurysm, Abdominal with a site in United States are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 122 studies in Aortic Aneurysm, Abdominal with a site in United States, or all of them as a file.
02

Study summary

This is a Prospective Registry study to collect imaging and clinical data both on patients with aortic aneurysm disease undergoing serial monitoring and on patients pre and post-endovascular repair, using ViTAA (The Sponsor) aortic mapping technology.

Read the detailed description

This a prospective, multi-center, registry of patients that are being assessed with the ViTAA software. Patients will be enrolled at selected North American centers in the US and Canada. The Registry will enroll patients from the following two populations:

  • patients who are scheduled and ultimately receive endovascular infrarenal aortic aneurysm repair (EVAR);
  • patients who do not yet qualify for infrarenal aortic aneurysm repair based on anatomic size criteria who are enrolled in a serial monitoring program.
03

Conditions studied

  • Abdominal Aortic Aneurysms
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  1. Patients who are booked for and then subsequently have undergone endovascular repair.
  2. Patients with infrarenal aortic aneurysms without indications for repair undergoing serial monitoring.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient is aged 18 years or over
  2. Infrarenal Aortic Aneurysm ≥ 45 mm in diameter.
  3. Patient meets on-IFU criteria for endovascular reconstruction

Exclusion criteria

Exclusion Criteria:

  1. Patient has a known or clinically suspected major connective tissue disorder, disorder, vasculitis, or aortic dissection.
  2. Patient has renal failure (defined as dialysis dependent or serum creatinine ≥2.0mg/dL or 175umol/L
  3. Patients with previous aortic reconstruction in the involved segment.
  4. Patients receiving oral or parenteral therapy for other unrelated disease. (Excludes inhaled corticosteroids).
  5. Patient has a sensitivity to contrast imaging agents.
  6. Patient has aortic dissection.
  7. Patient has atrial fibrillation.
  8. Patient has arrhythmia.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • Patients who are booked for and then subsequently have undergone endovascular repair.

    Patients who are scheduled and ultimately receive on-IFU endovascular infrarenal aortic aneurysm repair (EVAR)

    Device: ViTAA Analysis

  • Patients with infrarenal AA without indications for repair undergoing serial monitoring

    Patients who do not yet qualify for the aortic aneurysm repair who are enrolled in a serial monitoring program

    Device: ViTAA Analysis

Interventions

  • DeviceViTAA Analysis

    Imaging Analysis Software

06

What researchers measure

Primary outcomes

  1. Composite of aneurysm rupture or critical growth.

    * Critical growth defined as an increase of \> 0.5 cm in any of the three growth measurements below * Critical growth defined as an increase of \> 0.5 cm in aortic diameter. * Critical growth defined as an increase of \> 0.5 cm in ILT. * Critical growth defined as an increase of \> 0.5 cm in aneurysm sac volume.

    Time frame: 6 months

  2. Composite of aneurysm rupture or critical growth.

    * Critical growth defined as an increase of \> 0.5 cm in any of the three growth measurements below * Critical growth defined as an increase of \> 0.5 cm in aortic diameter. * Critical growth defined as an increase of \> 0.5 cm in ILT. * Critical growth defined as an increase of \> 0.5 cm in aneurysm sac volume.

    Time frame: 1 year

Secondary outcomes

  1. CHUM Ancillary Ultrasound Study

    For patients recruited at the CHUM: 1. Correlation between ultrasound and multiphase CT based strain and RAW values 2. Correlation between AAA growth and ultrasound-based strain and RAW maps

    Time frame: 6 months

  2. CHUM Ancillary Ultrasound Study

    For patients recruited at the CHUM: 1. Correlation between ultrasound and multiphase CT based strain and RAW values 2. Correlation between AAA growth and ultrasound-based strain and RAW maps

    Time frame: 1 year

07

Study locations

8 of 8 sites recruiting
  • UAB - University of Alabama in Birmingham Hospital
    Birmingham, Alabama 35233, United States
    Recruiting
    • Rebecca St John · Contactrstjohn@uabmc.edu
    • Adam Beck, MD · Principal investigator
  • MGH - Massachusetts General Hospital Fireman Vascular Center
    Boston, Massachusetts 02114, United States
    Recruiting
  • UNC - University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27514, United States
    Recruiting
  • University of Washington
    Seattle, Washington 98104, United States
    Recruiting
    • Allison Larimore, MSN, RN, CCRN · Contactalari@uw.edu · 206-744-8257
    • Sonja Katt · Contactskatt@uw.edu · 206-744-8257
    • Benjamin Starnes, MD · Principal investigator
  • UCGY - University of Calgary, Peter Lougheed Center
    Calgary, Alberta T1Y 6J4, Canada
    Recruiting
  • UHN - University Health Network - Toronto General Hospital
    Toronto, Ontario M5G 2C4, Canada
    Recruiting
  • CHUM - Centre Hospitalier de l'Université de Montréal
    Montreal, Quebec H2X 3E4, Canada
    Recruiting
  • MUHC - McGill University Health Centre
    Montreal, Quebec H4A 3J1, Canada
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Dec 2026, 60 months after the start.

Of 91 observational studies under Aortic Aneurysm, Abdominal, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 83. This study's planned 60 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2021
First posted
Aug 13, 2021
StartActual
Dec 15, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05004051
Lead sponsor
ViTAA Medical Solutions
Responsible party
Dr Mark Farber (Principal Investigator, ViTAA Medical Solutions) — Principal investigator
First posted
Aug 13, 2021
Start date
Dec 15, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 19, 2025

Study contacts

Denis Bilodeau
Contact
denisbilodeau@vitaamedical.com
5145728673
Mark Farber
principal investigator · University of North Carolina, Chapel Hill

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion